Useful as a tumor marker for squamous cell carcinomas of the head and neck, uterine cervix, lung, vulva, and esophagus.
Quantitative Enzyme-Linked Immunosorbent Assay
Serum separator tube or plain red.
Allow specimen to clot completely at room temperature. Separate serum from cells ASAP or within 2 hours of collection. Transfer 2 mL serum to an ARUP Standard Transport Tube. (Min: 0.3 mL)
Specimens exposed to repeated freeze/thaw cycles.
After separation from cells: Ambient: 48 hours; Refrigerated: 4 months; Frozen: 4 months
2.2 ng/mL or less
SCC antigen levels alone should not be interpreted as evidence to the presence or absence of malignant disease. In patients with known or expected cancer, other tests and procedures must be considered for diagnosis and patient management. Results obtained with different assay methods or kits cannot be used interchangeably.
Compliance Statement A: For laboratory developed tests using a manufacturer labeled ASR as the reagent providing the specificity of the assay. Analyte Specific Reagent. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, the FDA has determined that such clearance or approval is not necessary.
|Component Test Code*||Component Chart Name||LOINC|
|0081054||Squamous Cell Carcinoma Antigen||9679-2|
- SCC Antigen